1. Home
  2. EYEN vs EVOK Comparison

EYEN vs EVOK Comparison

Compare EYEN & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYEN
  • EVOK
  • Stock Information
  • Founded
  • EYEN 2014
  • EVOK 2007
  • Country
  • EYEN United States
  • EVOK United States
  • Employees
  • EYEN N/A
  • EVOK N/A
  • Industry
  • EYEN Biotechnology: Pharmaceutical Preparations
  • EVOK Biotechnology: Pharmaceutical Preparations
  • Sector
  • EYEN Health Care
  • EVOK Health Care
  • Exchange
  • EYEN Nasdaq
  • EVOK Nasdaq
  • Market Cap
  • EYEN 3.7M
  • EVOK 4.2M
  • IPO Year
  • EYEN 2018
  • EVOK 2013
  • Fundamental
  • Price
  • EYEN $1.12
  • EVOK $2.45
  • Analyst Decision
  • EYEN Hold
  • EVOK
  • Analyst Count
  • EYEN 4
  • EVOK 0
  • Target Price
  • EYEN $2.00
  • EVOK N/A
  • AVG Volume (30 Days)
  • EYEN 495.7K
  • EVOK 27.3K
  • Earning Date
  • EYEN 05-14-2025
  • EVOK 03-13-2025
  • Dividend Yield
  • EYEN N/A
  • EVOK N/A
  • EPS Growth
  • EYEN N/A
  • EVOK N/A
  • EPS
  • EYEN N/A
  • EVOK N/A
  • Revenue
  • EYEN $31,832.00
  • EVOK $10,249,415.00
  • Revenue This Year
  • EYEN $23,413.60
  • EVOK $99.03
  • Revenue Next Year
  • EYEN $400.98
  • EVOK $60.15
  • P/E Ratio
  • EYEN N/A
  • EVOK N/A
  • Revenue Growth
  • EYEN 2557.09
  • EVOK 97.84
  • 52 Week Low
  • EYEN $1.06
  • EVOK $2.40
  • 52 Week High
  • EYEN $124.80
  • EVOK $12.32
  • Technical
  • Relative Strength Index (RSI)
  • EYEN 27.91
  • EVOK 26.36
  • Support Level
  • EYEN $1.06
  • EVOK $2.51
  • Resistance Level
  • EYEN $1.19
  • EVOK $2.81
  • Average True Range (ATR)
  • EYEN 0.10
  • EVOK 0.29
  • MACD
  • EYEN 0.05
  • EVOK -0.02
  • Stochastic Oscillator
  • EYEN 9.05
  • EVOK 8.12

About EYEN Eyenovia Inc.

Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

Share on Social Networks: